Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City

AIDS and Behavior

Volumn 17, Issue 6, 2013, Pages 2180-2184

  Rucinski, Katherine B ^a   Mensah, Nana P ^a   Sepkowitz, Kent A ^a,b   Cutler, Blayne H ^a   Sweeney, M Monica ^a   Myers, Julie E ^a,c  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

HIV prevention; MSM; Pre exposure prophylaxis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; HEALTH CARE DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MALE HOMOSEXUALITY; PSYCHOLOGICAL ASPECT; SERODIAGNOSIS; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; DATA COLLECTION; EDUCATIONAL STATUS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; NEW YORK CITY; YOUNG ADULT;

EID: 84879028331     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0443-y     Document Type: Article

References (20)

1. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995;270(5239):1197-9.
2. Kellerman SE, Hutchinson AB, Begley EB, Boyett BC, Clark HA, Sullivan P. Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004. J Acquir Immune Defic Syndr. 2006;43(3):376-7.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
4. Centers for Disease Control and Prevention. Interim Guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR. 2011;60(3):65-68.
5. US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm312210.htm. Accessed 5 Sept 2012.
6. Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care and STDs. 2010;24(11):689-91.
7. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77-83.
8. Liu AY, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241-7.
9. Mehta SA, Silvera R, Bernstein K, Holzman RS, Aberg JA, Daskalakis DC. Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect. 2011;87(4):344-8.
10. Leonardi M, Lee E, Tan DH. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS. 2011;22(12):738-41.
11. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-34.
12. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
13. Centers for Disease Control and Prevention. National HIV Behavioral Surveillance. http://www.cdc.gov/hiv/bcsb/nhbs/index.htm. Accessed 7 Sept 2012.
14. Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7(3):e33119.
15. Jay JS, Gostin LO. Ethical challenges of preexposure prophylaxis for HIV. JAMA. 2012;308(9):867-8.
16. Leibowitz AA, Parker KB, Rotheram-Borus MJ. A US policy perspective on oral preexposure prophylaxis for HIV. Am J Public Health. 2011;101(6):982-5.
17. Bernstein KT, Liu KL, Begier EM, Koblin B, Karpati A, Murrill C. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches. Arch Intern Med. 2008;168(13):1458-64.
18. Torrone EA, Thomas JC, Maman S, et al. Risk behavior disclosure during HIV test counseling. AIDS Patient Care and STDs. 2010;24(9):551-61.
19. Wimberly YH, Hogben M, Moore-Ruffin J, Moore SE, Fry-Johnson Y. Sexual history-taking among primary care physicians. J Natl Med Assoc. 2006;98(12):1924-9.
20. New York City Department of Health and Mental Hygiene. New York City HIV/AIDS Annual Surveillance Statistics. http://www.nyc.gov/html/doh/downloads/ pdf/ah/surveillance2010-tables-all.pdf. Accessed 5 Sept 2012. Department of Health and Mental Hygiene